ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCOby krapalmJune 1, 2026PR Newswire (category)
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLCby krapalmJune 1, 2026PR Newswire (category)
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancerby krapalmJune 1, 2026PR Newswire (category)
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026by krapalmJune 1, 2026PR Newswire (category)
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Buildersby krapalmJune 1, 2026PR Newswire (category)
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment’s Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczemaby krapalmJune 1, 2026PR Newswire (category)
Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meetingby krapalmJune 1, 2026PR Newswire (category)
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Conceptby krapalmJune 1, 2026PR Newswire (category)
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026by krapalmMay 31, 2026PR Newswire (category)
BLUETTI Launches EOFY Sale on Power Solutions with Up to 44% OFFby krapalmMay 31, 2026PR Newswire (category)
Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data providerby krapalmMay 31, 2026PR Newswire (category)
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Sessionby krapalmMay 31, 2026PR Newswire (category)
Meta ทุ่มพัฒนา AI Wearables ใหม่ เตรียมเปิดตัวจี้อัจฉริยะและแว่นตาหลายรุ่นby krapalmMay 31, 2026May 31, 2026Tech (category)
AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Techby krapalmMay 31, 2026PR Newswire (category)
Xiaomi 17T เตรียมเปิดตัว 4 มิถุนายนนี้ พร้อมเผยสเปกกล้อง Leica และชิป Dimensity 8500 Ultraby krapalmMay 31, 2026May 31, 2026Tech (category)
Acer เปิดตัว HL6820GTV เลเซอร์โปรเจคเตอร์ 4K พ่วง Google TV ตอบโจทย์คอเกม 144Hzby krapalmMay 31, 2026May 31, 2026Tech (category)
เปิดฉากอลังการ! TRK Group เนรมิตงาน THAIFEX 2026 เป็น “สวนสนุกในวัยเด็ก” ขยายกลุ่มลูกค้า ด้วยคอนเซ็ปต์ Made For Your Inner Child รีแบรนด์ “ลิน” ก้าวสู่ยุคใหม่by krapalmMay 31, 2026PR News (category)
Solis เปิดเกม “Energy Intelligence” โชว์โซลูชัน Storage ครบทุกระดับในงาน SNEC 2026by krapalmMay 31, 2026PR News (category)
Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contendersby krapalmMay 31, 2026PR Newswire (category)
Xiaomi เปิดตัวเครื่องปรับอากาศ Mijia Ultra 3HP พลังสูง 11,000W พร้อม HyperOS Connect ในจีนby krapalmMay 31, 2026May 31, 2026Tech (category)
ภาพหลุด iPhone 18 Pro เผยดีไซน์คุ้นตา พร้อม 4 สีใหม่สะดุดใจby krapalmMay 31, 2026May 31, 2026Tech (category)
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancetby krapalmMay 31, 2026PR Newswire (category)
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026by krapalmMay 31, 2026PR Newswire (category)
THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®by krapalmMay 31, 2026PR Newswire (category)
THE KILLERS ระเบิดความมันส์ในโชว์เปิดสนามนัดชิงชนะเลิศการแข่งขันยูฟ่าแชมเปียนส์ลีกที่นำเสนอโดย PEPSI®by krapalmMay 31, 2026PR Newswire (category)
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCOby krapalmMay 30, 2026PR Newswire (category)
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancetby krapalmMay 30, 2026PR Newswire (category)
Duke-NUS graduates biggest class yet, with new doctors drawn from business, engineering and the humanitiesby krapalmMay 30, 2026PR Newswire (category)
